Cigna Group stock holds gains as higher premiums lift 2024 outlook
Published on 07/18/2026 at 07:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cigna Group stock has been supported in 2024 by growing premiums and disciplined cost management, with the U.S. health insurer (ISIN US1255231003) pointing to higher revenue and earnings in its most recent full-year figures as of 31 December 2023.
Revenue up around 8 percent in 2023
According to the companys latest annual reporting for fiscal 2023, Cigna Group generated total revenue of roughly $195 billion, up from about $181 billion in 2022, implying growth of approximately 8% year on year over the period.
Within this total, the company highlighted continued expansion in its health services and insurance operations, underpinned by higher medical and pharmacy volumes as well as premium increases across its core U.S. commercial and government lines.
EPS grows double digits and margins improve
On the bottom line, Cigna Group reported adjusted earnings per share for 2023 that were more than 10% above the prior year level, reflecting both the higher revenue base and an improvement in underwriting profitability.
Management also pointed to an improved medical care ratio for the year compared with 2022, indicating that claims costs consumed a slightly smaller share of premium revenue and supporting a modest expansion in margins.
More on Cigna Group fundamentals
Further company information, regulatory filings, and news updates for Cigna Group can be found in the dedicated ISIN overview and via the companys own investor relations pages.
Evernorth drives health services growth
A key contributor to Cigna Groups scale is its Evernorth health services segment, which provides pharmacy benefit management, care delivery, and data-driven health solutions to employers, health plans, and government clients.
In the 2023 reporting period, health services operations within the group accounted for well over half of consolidated revenue, reflecting the importance of this segment in diversifying earnings beyond traditional medical insurance premiums and stabilizing cash flows over time.
Cigna Group stock and valuation context
Cigna Group stock is listed on the New York Stock Exchange under the ticker CI, giving the company a substantial equity market presence among large-cap U.S. health insurers.
Based on recent market data for 2024, the company commands a market capitalization in the range of tens of billions of U.S. dollars, placing it alongside other major managed-care peers in terms of investor attention and index representation.
Cigna Group at a glance
- Company: The Cigna Group, Inc.
- ISIN: US1255231003
- Ticker: NYSE: CI
- Trading venue: NYSE
- Sector / Industry: Health Care / Managed Health Care
- Index membership: S&P 500
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
